Using a combination of NOXA and ABT-263 to inhibit all pro-survival proteins (i.e. MCL-1, BCL-XL, BCL-2), we observed efficient cell death in HNSCC cells. The gene discussed is BCL2; the disease is head and neck squamous cell carcinoma.